Technology
The answers your security review is going to ask for
Data handling and IP ownership derail more good technical relationships than pricing does. So here are our positions, in public, before you have to ask.
Who owns what
| Asset | Owner |
|---|---|
| Your input data | You |
| Results, reports and data generated for you | You |
| Protocols developed specifically for your programme | You, with transfer documentation |
| Our models, pipelines and platform | Prognica Labs |
| Jointly developed IP | Negotiated explicitly, in writing, before work starts |
We do not use customer data to train models offered to other customers without a specific, written agreement to do so.
Data residency
In-region deployment options are available for the platform, and data flows are documented in every proposal. Requirements vary by jurisdiction - Gulf states, Canadian provinces and Brazil each impose different obligations. Raise yours at the first meeting so it is designed in.
Access and audit
- Single sign-on with your identity provider
- Role-based access control
- Full audit trails on platform activity
- Defined data retention and deletion on request
Confidentiality
Mutual confidentiality agreements are standard and can be executed before any technical discussion. Our named scientific and manufacturing partner operates under back-to-back confidentiality obligations.
Security review
We will provide our security and data-handling documentation on request, ahead of a first meeting if that speeds your process. Assume we have been through this before, because we have.
Related
Where to read next
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.